Kyle J Armbruster

age ~49

from Douglassville, PA

Get Report

Also known as:

Connected to:

Kyle Armbruster Phones & Addresses

Polymorphic And Amorphous Salt Forms Of Squalamine Dilactate
view source
US Patent:

20070010504, Jan 11, 2007
Filed:

Apr 25, 2006
Appl. No.:

11/410098
Inventors:

Eric Chellquist - Plymouth Meeting PA, US
Mary Doubleday - Plymouth Meeting PA, US
Charles Gilbert - Plymouth Meeting PA, US
Xuehai Zhang - Plymouth Meeting PA, US
Michael McLane - Plymouth Meeting PA, US
Kyle Armbruster - Plymouth Meeting PA, US
Roy Levitt - Plymouth Meeting PA, US
International Classification:

A61K 31/56
C07J 41/00
US Classification:

514178000, 552515000
Abstract:

The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.

Polymorphic And Amorphous Salt Forms Of Squalamine Dilactate
view source
US Patent:

20120022035, Jan 26, 2012
Filed:

Jun 23, 2011
Appl. No.:

13/166911
Inventors:

Eric Chellquist - Plymouth Meeting PA, US
Mary Doubleday - Plymouth Meeting PA, US
Charles Gilbert - Plymouth Meeting PA, US
Xuehai Zhang - Plymouth Meeting PA, US
Michael McLane - Plymouth Meeting PA, US
Kyle Armbruster - Plymouth Meeting PA, US
Roy C. Levitt - Plymouth Meeting PA, US
International Classification:

A61K 31/575
A61P 29/00
A61P 9/10
A61P 27/02
C07J 41/00
A61P 35/00
US Classification:

514182, 552521
Abstract:

The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.